Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 45 out of 100. Getting a diagnosis

Topic: Risk, prevention and care in population studies

Plain-language summary

Study-specific algorithms yielded comparable dementia prevalence estimates: 10.8 % in NHATS and 11.1 % in HRS-HCAP. Co-calibrated scores showed similar distributions and had acceptable reliability, with similar dementia cutpoints. In both studies, sensitivity was higher among lower-educated (vs. higher educated) and non-White (vs. non-Hispanic White) groups. Co-calibrated populations with dementia in both studies had similar age and gender distributions but differed somewhat in education levels and race/ethnicity profiles. NHATS and HRS-HCAP both provide reliable cognitive function measures and dementia prevalence estimates for older Americans. Co-calibrated scores based on each study's cognitive test battery provide a valid and feasible approach for comparative US research. Better aligned algorithmic approaches across studies could strengthen opportunities for comparative studies of disparities in the US context using the co-calibration approach.

What this study adds

Evidence grade: Low

The record lists 5,696 participants. This study found that co-calibrated cognitive scores from two large studies yielded comparable dementia prevalence estimates and had acceptable reliability. Co-calibrated scores provide a valid and feasible approach for comparative research on dementia in the US.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Zhang, Y. S., Gross, A. L., Dougherty, R. J., Kobayashi, L. C., Schrack, J. A., & Freedman, V. A. (2025). Co-calibration of cognitive performance in the National Health and Aging Trends Study with the Health and Retirement Study's Harmonized Cognitive Assessment Protocol: Implications for dementia classification. SSM - Population Health. https://doi.org/10.1016/j.ssmph.2025.101796

Vancouver

Zhang YS, Gross AL, Dougherty RJ, Kobayashi LC, Schrack JA, Freedman VA. Co-calibration of cognitive performance in the National Health and Aging Trends Study with the Health and Retirement Study's Harmonized Cognitive Assessment Protocol: Implications for dementia classification. SSM - Population Health. 2025. doi:10.1016/j.ssmph.2025.101796. PMID: 40474946.

BibTeX

@article{zhang2025-40474946,
  author  = {Zhang, Yuan S and Gross, Alden L. and Dougherty, Ryan James and Kobayashi, Lindsay C. and Schrack, Jennifer A. and Freedman, Vicki A.},
  title   = {{Co-calibration of cognitive performance in the National Health and Aging Trends Study with the Health and Retirement Study's Harmonized Cognitive Assessment Protocol: Implications for dementia classification}},
  journal = {SSM - Population Health},
  year    = {2025},
  doi     = {10.1016/j.ssmph.2025.101796},
  pmid    = {40474946},
  url     = {https://doi.org/10.1016/j.ssmph.2025.101796}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that co-calibrated cognitive scores from two large studies yielded comparable dementia prevalence estimates and had acceptable reliability. Co-calibrated scores provide a valid and feasible approach for comparative research on dementia in the US.

Study details

How this study scored 45/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 45 of 100.45 of 100 points earned55 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (SSM - Population Health)
Journal's citation record 1 / 4 SSM - Population Health: journal h-index 88 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 3 / 4 5,696 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Vicki A. Freedman: h-index 59 (OpenAlex, whole career)
Institution's track record 2 / 3 Johns Hopkins University: institution h-index 2,306 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 5 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40474946)
Free to read 2 / 2 Free to read
Total 45 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 19.

Related studies in Getting a diagnosis from nearby years

Also tagged “prevalence”

1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →